- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
Intervention: Pharmacological intervention
This refers to the drug, therapy, or factor being studied in a clinical trial or observational study. Examples include antiviral agents monoclonal antibodies, corticosteroids, vaccines and other pharmacological agents
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Adults
- General population
- Elderly
- Outpatient clinic
- Community
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Adults
- General population
- Hospital wide
- Intensive care unit
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute SARS-CoV-2
- Avian Influenza
- Influenza
- Pharmacological intervention
- Immnunomodulator
- Baricitinib
- Statins
- Simvastatin
- Adults
- Primary care
- Community
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute SARS-CoV-2
- Avian Influenza
- Influenza
- Pharmacological intervention
- Nitric Oxide Nasal Spray
- Adults
- Paediatric
- Hospital wide
- Intensive care unit
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Post-COVID-19
- Acute SARS-CoV-2
- Avian Influenza
- Influenza
- Pharmacological intervention
- Immnunomodulator
- Corticosteroid
- Baloxavir
- Oseltamivir
- Adults
- Paediatric
- Hospital wide
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Avian Influenza
- Influenza
- Pharmacological intervention
- Antivirals
- Corticosteroid
- Baloxavir
- Oseltamivir
- Adults
- Fragile population
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Molnupiravir
- Adults
- General population
- Elderly
- Paediatric
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Antivirals
- Tecovirimat
- Adults
- People at high risk of STIs
- People living with HIV
- PrEP users
- Hospital wide
- Outpatient clinic
- Monkeypox virus
- Monkeypox virus infection
- Blood sample
- Pharmacological intervention
- Vaccination
- JYNNEOS
- Hospital wide
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Monoclonal antibodies
- Immnunomodulator
- Antineoplastic agent
- Imatinib
- Infliximab